- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 16, 2018
Emerging Company Profile
Cirius safety
How Cirius’ insulin sensitizer could avoid AEs of Actos, Avandia in NASH
BioCentury | Apr 14, 2017
Finance
More NASH cash
Why investors are backing Cirius’ next-generation insulin sensitizer in NASH
Items per page:
1 - 6 of 6